These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. FDA acts on estrogen, progestin labeling. FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006 [No Abstract] [Full Text] [Related]
6. History of FDA patient package insert requirements. Am J Hosp Pharm; 1980 Dec; 37(12):1660-1. PubMed ID: 7004180 [No Abstract] [Full Text] [Related]
7. Did FDA jump the gun? Archambault GF Hosp Formul; 1977 Oct; 12(10):722. PubMed ID: 10305387 [No Abstract] [Full Text] [Related]
8. FDA proposes patient package inserts for most drugs. Mayberger HW; Bell BJ Leg Aspects Med Pract; 1979 Oct; 7(10):42-4. PubMed ID: 263192 [No Abstract] [Full Text] [Related]
9. Estrogen PPIs. An FDA survey. Morris LA; Myers A; Gibbs P; Lao C Am Pharm; 1980 Jun; NS20(6):22-6. PubMed ID: 7395715 [No Abstract] [Full Text] [Related]
10. FDA proposes that patient package insert program be rescinded. Hospitals; 1982 Feb; 56(4):84. PubMed ID: 7054117 [No Abstract] [Full Text] [Related]
11. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691 [TBL] [Abstract][Full Text] [Related]
12. FDA chief says demand by patients for more drug information is genuine. Health Educ Rep; 1980 Jul; 2(15):4-5. PubMed ID: 10247629 [No Abstract] [Full Text] [Related]
13. FDA's Rx for better medication information. Farley D FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787 [TBL] [Abstract][Full Text] [Related]
14. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer. Goyan JE Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484 [No Abstract] [Full Text] [Related]
15. Developing drug information for patients. Hecht A FDA Consum; 1977 Sep; 11(7):16-9. PubMed ID: 10304999 [No Abstract] [Full Text] [Related]
17. The legal status of patient package inserts. Whitman JA Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809 [No Abstract] [Full Text] [Related]
18. How does the FDA affect you and your practice? Novitch M Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685 [No Abstract] [Full Text] [Related]
19. Drug labeling and promotion: evolution and application of regulatory policy. Hayes TA Food Drug Law J; 1996; 51(1):57-73. PubMed ID: 11794353 [No Abstract] [Full Text] [Related]